Jane Ryan - 16 Apr 2025 Form 4 Insider Report for Neuphoria Therapeutics Inc. (NEUP)

Role
Director
Signature
/s/ Elaine Wangsawidjaja, Attorney-in-Fact for Jane Ryan
Issuer symbol
NEUP
Transactions as of
16 Apr 2025
Transactions value $
$0
Form type
4
Filing time
18 Apr 2025, 08:02:08 UTC
Previous filing
08 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUP Restricted Stock Units Award $0 +6,783 +29.49% $0 7,013 16 Apr 2025 Common Stock 6,783 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
F2 Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.